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Bone histology of distal renal tubular acidosis patients
showed decreased bone formation with impaired bone
matrix mineralization that is not entirely explained by an
alteration in the mineral balance. Data from in vitro studies
suggests a direct inhibitory effect of metabolic acidosis on
osteoblast function. We investigated the effects of chronic
metabolic acidosis on osteoblast differentiation from
mesenchymal stem cells (MSCs). Human MSCs were allowed
to differentiate into osteoblasts in culture. Concentrated
hydrochloric acid was added to the medium to lower the
bicarbonate concentration and pH. The expression of various
osteoblastic genes and proteins and bone matrix
mineralization were examined. Chronic metabolic acidosis
enhanced the messenger RNA (mRNA) and protein
expression of early osteoblast transcription factor, runx-2,
whereas inhibiting osterix and having no effect on ATF-4. The
expression of type I collagen, the most abundant bone matrix
protein, was increased following the same pattern of runx-2.
Likewise, metabolic acidosis slightly enhanced the expression
of mature osteoblastic gene, osteocalcin. Study on
mineralization revealed suppressed alkaline phosphatase
mRNA and enzyme activity. Despite the augmented collagen
deposit in acidic culture, bone matrix mineralization was
impaired. In conclusion, chronic metabolic acidosis alters
osteoblast differentiation from MSCs through its diverse
effect on osteoblastic genes and proteins resulting in an
impairment of bone formation.
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Chronic metabolic acidosis is commonly associated with
chronic kidney disease and distal renal tubular acidosis
(dRTA). In dRTA, the presence of acidosis results in various
metabolic consequences, including negative calcium and
phosphate balance and osteopenia.1–3 Bone histologic studies
of dRTA patients revealed findings of decreased osteoblast
number, suppressed bone formation, and varying degree of
impaired bone matrix mineralization.4–6 Although the
abnormal bone remodeling may be largely due to an
alteration in mineral balance, the direct effect of metabolic
acidosis on bone cells may also play a significant role.
Previous in vitro studies by Krieger et al.7 reported the
reduction in type I collagen synthesis and alkaline phospha-
tase enzyme activity in bone organ culture after 48-h
incubation in acidic medium. Furthermore, chronic meta-
bolic acidosis was found to diminish the expression of bone
matrix proteins such as matrix Gla protein and osteopontin
and impaired bone matrix mineralization.8 On the other
hand, heightened expression of RANKL and parathyroid
hormone receptor was observed.9,10 This evidence supports
a direct and diverse effect of metabolic acidosis on
osteoblasts.
Osteoblasts originate from mesenchymal stem cells
(MSCs) in the bone marrow. These cells contribute to
replacement of osteoblasts in bone turnover and fracture
healing throughout life. Under appropriate conditions,
multipotent MSCs can also differentiate into chondrocytes,
adipocytes, and fibroblasts. A wide variety of systemic
and local factors appears to regulate osteoprogenitor
proliferation and differentiation, a sequence that is char-
acterized by series of cellular and molecular events distin-
guished by differential expression of osteoblast-associated
genes.11 In vitro, the induction of osteogenic differentiation
can be achieved in the presence of dexamethasone (DEX),
b-glycerophosphate, and ascorbate phosphate.12 As meta-
bolic acidosis may have a direct effect on osteoblasts and
possibly interfere with osteoblast differentiation, we studied
the sequential changes in the expression of osteoblastic
genes in human MSCs during osteogenic induction to
examine the effect of chronic metabolic acidosis on osteoblast
differentiation.
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RESULTS
Flow cytometry of freshly isolated bone marrow mono-
nuclear cells revealed at least two cell populations, the
predominant hematopoietic cells (CD45pos or CD34pos) and
the fewer MSCs (CD45negCD34negCD105pos) (Figure 1a and
b).13 During expansion, MSCs adhered to the culture plate,
whereas hematopoietic cells detached and were eventually
eliminated. At the end of the fourth passage, the adherent
MSCs became homogeneous, exhibited MSC surface markers
(CD14negCD45negCD34negHLA-DRnegCD105pos) (Figure 1c
and f) with characteristic spindle-shaped morphology
(Figure 2a). To demonstrate their multipotency, MSCs were
cultivated in the presence of osteogenic inducing medium
(OM) and adipogenic inducing medium. After 20 days in
culture in OM, cell colonies displayed bone-like nodular
aggregates of matrix mineralization (Figure 2b). MSCs
cultivated in the absence of OM never mineralized (data
not shown). Lipid-rich vacuoles were observed after 21 days
of adipogenic induction (Figure 2c). In order to generate
metabolic acidosis in vitro, concentrated hydrochloric acid
(HCl) was added to the medium to lower bicarbonate
concentration. The medium pH before feeding are shown in
Table 1. The toxicity of HCl on MSCs was tested for upto 24 h
in culture. Increasing metabolic acidosis did not result in any
significant toxicity to the cells (Figure 3a). However, cell
proliferation declined at pH below 7.25 (Figure 3b).
The effect of chronic metabolic acidosis on the expression
of osteoblast transcription factors, runx2 (or cbfa1), which is
necessary for osteoblast commitment,14 osterix, a transcrip-
tion factor downstream of runx-2,15 and ATF4, a regulator of
runx2 activity and osteoblast differentiation,16,17 was next
examined. When MSCs reached 50–60% confluency, the
medium was replaced with OM with or without HCl (day 0).
Negative control cells were grown in the absence of OM. Cells
were harvested at 5-day interval for further examination by
quantitative real-time reverse transcription-polymerase chain
104
103
102
101
100 101 102 103 104
CD
45
 T
ric
ol
or
104
103
102
101
100 101 102 103 104
CD
34
 F
IT
C
CD105 PE
104
103
102
101
100 101 102 103 104
CD
14
 P
E
CD45 FITC
104
103
102
101
100 101 102 103 104
FL
1-
H
ei
gh
t
Anti-HLA-DR PE
104
103
102
101
100 101 102 103 104
FL
2-
H
ei
gh
t
FL
2-
H
ei
gh
t
104
103
102
101
100 101 102 103 104
CD34 FITC
CD105 FITC
CD105 PE
a b
c d
e f
Figure 1 | Flow cytometry analysis. Flow cytometry of bone marrow mononuclear cells before plating for (a) CD45, CD105, (b) CD34, CD105
and after the fourth passage for (c) CD14, CD45, (d) CD34, (e) HLA-DR, and (f) CD105.
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reaction (PCR) and Western blot analyses. As shown in
Figure 4a and b, runx2 messenger RNA (mRNA) expression
was enhanced more than sixfold in the presence of OM,
whereas the increase of less than twofold was observed in
negative controls. The levels of runx2 mRNA were greater in
acidosis. Osterix expression attained its peak at day 15 in
both donors (Figure 4c and d). Unlike runx2, the expression
of osterix mRNA was suppressed in metabolic acidosis.
Despite the adverse influence on runx2 and osterix, metabolic
acidosis seemed to have no significant effect on ATF4
expression (Figure 4e). Consequently, we examined the
expression of type I collagen, the most abundant bone
matrix protein produced by osteoblasts as well as a target
gene for runx2.18 Type I collagen mRNA from both donors
were enhanced more than sixfold in the presence of OM and
appeared to follow the same pattern of runx2 (Figure 4g and
h). Less than fourfold increase were observed in negative
controls. Corresponding to runx2, collagen mRNA was
greater in acidosis. Similar changes were observed but to a
lesser extent in negative controls. The representative Western
blot of runx2, osterix, and ATF4 shown in Figure 5 confirmed
the changes of mRNA. The amount of collagen deposition
was determined by Sirius red staining. Sirius red has been
shown to have high affinity for type I collagen and does not
stain other major components of extracellular matrix. The
quantification method has been shown to be sensitive and
specific for collagen deposited on cultured osteoblasts.19
Similar to the mRNA, the increase in collagen deposit after
normalization by protein concentration was observed in cells
cultivated in acidic environment (Figure 6a). Next, we
proceed to evaluate the expression of osteocalcin, a matrix
protein normally present in mature osteoblasts and upregu-
lated later in the mineralization period.18 As shown in Figure
4f, upregulation of osteocalcin occurred after day 28 in
culture. A slight but significant increase in osteocalcin
expression was noted at day 35 in acidosis.
Following the period of matrix protein synthesis, miner-
alization occurs through the deposition of apatite crystals
resulting in a formation of mature mineralized bone.11 To
determine whether chronic metabolic acidosis impaired bone
matrix mineralization, alkaline phosphatase, an enzyme
necessary for mineralization, was examined.18 Alkaline
phosphatase mRNA raised upto 24-fold in the presence of
OM, whereas less than fivefold increase was observed in
negative controls (Figure 4i). Metabolic acidosis markedly
suppressed alkaline phosphatase mRNA expression. In pH
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Figure 2 | Morphology of human MSCs. Phase-contrast microscopy
demonstrates (a) the spindle-shaped morphology of MSCs grown in
the absence of OM, (b) nodular aggregates of mineralization in the
presence of OM for 28 days, and (c) adipocytes with lipid-rich
vacuoles.
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Figure 3 | Cell cytotoxicity and proliferation assay. MSCs were cultured in the absence of OM and HCl (pH 7.4) and with increasing amount of
HCl (pH 7.25, 7.15, and 7). (a) Cell cytotoxicity as evaluated by lactate dehydrogenase-cytotoxicity assay. (b) Cell proliferation by 3-(4,5-dimethyl-
thiazolyl-2)-2,5-diphenyltetrazolium bromide assay. There was no significant difference in the cytotoxicity assay. Results represent an average of
three experiments. aPo0.05 compared to day 0, bPo0.05 compared to pH 7.4, *Po0.05 compared to pH 7.25 and 7.15, and #Po0.05 compared
to pH 7.25.
Table 1 | Initial medium pH measurements
HCl (ll/ml of medium) pH pCO2 (mm Hg) HCO3 (meq/l)
0 7.4 44.2 31.5
1 7.25 43.9 26.6
2 7.15 45.7 21.8
3 7 46.4 15.9
HCl, hydrochloric acid; HCO3, medium bicorbonate; pCO2, partial pressure of
carbondioxide.
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7.15, despite the gradual increase in alkaline phosphatase
mRNA with time, the levels were less than those of pH 7.4 at
all time points. Negative controls also displayed similar
changes. The product of alkaline phosphatase gene was also
examined by evaluating the enzyme activity. As shown in
Figure 6b, exposure to acidic medium suppressed alkaline
phosphatase enzyme activity. In pH 7.4, the enzyme activity
raised rapidly reaching plateau by day 10. This upregulation
was retarded by metabolic acidosis. Similar changes were
noted in the negative controls. Dose–response experiments of
the mRNA expression are shown in Figure 7. Corresponding
to the data from time course, metabolic acidosis enhanced
the expression of runx2, collagen, and osteocalcin (Figure
7a), had no effect on ATF4 and suppressed osterix and
alkaline phosphatase (Figure 7b). Further examination of
mineral deposition by von Kossa staining revealed the
presence of mineralized nodules starting from day 21 in pH
7.4 (Figure 8a). The delay in bone matrix mineralization was
observed in metabolic acidosis. Mineral deposition occurred
at day 28 in pH 7.25, day 35 in pH 7.15, and never appeared
at all in pH 7. Figure 8b displays cuboidal-shaped osteoblasts
at day 28 in pH 7 without mineral deposition. Despite the
absence of mineralization, Sirius red staining confirmed the
presence of collagen-containing matrix nodules in these
cultures (Figure 8c). Despite the decrease in cell proliferation
during acidosis, the amount of collagen deposition appeared
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Figure 4 | Time course of the effect of chronic metabolic acidosis on the expression of osteoblastic genes. MSCs were grown in the
presence of OM without HCl (pH 7.4 –K–) and with HCl (pH 7.15 - -m- -). Negative controls were cultivated in the absence of OM (pH 7.4 - -J- -,
and pH 7.15 - -n- -). Expression levels of mRNA normalized by 18s rRNA are expressed as fold increase from day 0. (a, c, e, f, g, and i) represent
data from donor 1. (b, d, and h) Represent data from donor 2. Results represent an average of 5–8 experiments except single experiment for
negative controls. aPo0.05 compared to day 0 or day 14 for osteocalcin, bPo0.05 compared to pH 7.4.
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comparable across different pHs. The enhanced collagen
production became evident after correction the amount of
collagen staining with protein concentration as shown
previously in Figure 6a. Quantification of bone matrix
mineralization revealed calcium deposition to be measurable
at day 14 and progressively increasing through day 35 (Figure
8d). The deposition was sluggish to absent in pH 7.25–7.
DISCUSSION
MSCs are characterized based on the positivity and negativity
of a set of marker proteins on their surface (CD105posCD73-
posCD44posCD14negCD45negand CD34neg), the ability to attach
to the plate during propagation and to differentiate into
multiple mesenchymal lineages such as osteocytes, chondro-
cytes, and adipocytes.13 Our MSCs showed characteristic cell
surface marker profile and were able to undergo osteogenic
and adipogenic differentiation under appropriate conditions.
In the study of experimental acidosis, the expression of
multiple osteoblastic genes and proteins was found to be
altered during different stages of osteoblast differentiation.
First, we examined the expression of three known essential
transcription factors, runx2, osterix, and ATF4. Homozygous
mutation of runx2 and osterix resulted in a complete lack of
bone formation with arrest of osteoblast differentiation.14,15
Although runx2 expression in osterix null mice was
unaltered, osterix transcript was absent in runx2 null mice
suggesting that osterix acts downstream of runx2.15 The
interaction of ATF4 and runx2 is required for the expression
of mature osteoblastic gene, osteocalcin.17 ATF4 deficiency
results in a delayed bone formation and low bone mass.16
Our report demonstrated that metabolic acidosis upregulates
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Figure 5 | The effect of chronic metabolic acidosis on the
expression of osteoblastic proteins. (a) Runx2, (b) osterix, and (c)
ATF4. MSCs were grown in the presence of OM without HCl (pH 7.4)
and with HCl (pH 7.15). Representative Western blot data of each
protein from three experiments are shown.
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Figure 6 | The amount of collagen staining and alkaline phosphatase enzyme activity. MSCs were grown in the presence of OM without
HCl (pH 7.4) and with increasing amount of HCl (pH 7.25, 7.15, and 7). Negative controls were cultivated in the absence of OM (pH 7.4 - -J- -,
and pH 7.15 - -n- -). (a) Collagen staining and (b) alkaline phosphatase enzyme activity were determined and normalized by protein
concentration. The collagen experiments were performed using MSCs from donor 2. Results represent an average of six experiments except
single experiment for negative controls. aPo0.05 compared to day 0, bPo0.05 compared to pH 7.4, *Po0.05 compared to pH 7.25 and 7.15,
and #Po0.05 compared to pH 7.25.
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runx2 whereas inhibiting osterix and having no effect on
ATF4 indicating a diverse impact of metabolic acidosis on
these transcription factors critical for osteoblast differentia-
tion. The examination of type I collagen, the most abundant
bone matrix protein,18 revealed an increased expression that
appeared to follow the same pattern to that of runx2. Type I
collagen is upregulated in the early period of osteoblast
differentiation accompanying that of runx2.11 Therefore, the
heightened expression of runx2 and collagen suggests
accelerated osteoblast differentiation during this early stage.
Considering type I collagen is one the target genes of runx2,20
binding of runx2 to its promoter would likely explain the
increase in its transcript as well as their parallel expressions.
Overexpression of runx2 in mice enhanced osteoblast
differentiation in the earlier period; however, these animals
were osteopenic as their osteoblasts were of less mature
phenotype suggesting that excess of runx2 may adversely
affects later stage of osteoblast differentiation.21
The period of bone matrix synthesis and maturation
follows the early period of osteoblast differentiation. During
this time, genes associated with bone cell phenotype and
noncollagenous bone matrix proteins emerged. For example,
alkaline phosphatase is usually increased upto 10-fold. Later
on in the mineralization period, the upregulation of
osteocalcin signifies terminally differentiated osteoblast.18 In
contrast to the stimulatory effect on runx2 and collagen,
chronic metabolic acidosis suppressed alkaline phosphatase
mRNA and enzyme activity. One of the functions of alkaline
phosphatase is hydrolysis of phosphate compound and
supply inorganic phosphate for matrix mineralization.
Osteomalacia occurs in patients who are genetically deficient
of this enzyme.22 Therefore, the reduction in alkaline
phosphatase is likely responsible for the impaired bone
matrix mineralization observed in our study. The diminution
of osterix and alkaline phosphatase indicates the regulation of
both genes is at least in part independent of runx2. In fact,
Lee et al.23 demonstrated osterix expression was independent
of runx2. In order to determine whether these osteoblasts
were able to differentiate until maturity, we proceed to
examine the expression of osteocalcin. Slight but significant
increase in osteocalcin suggests these cells were able to
differentiate and reach maturity. Osteocalcin is a known
target gene of runx2 and its expression requires cooperative
interactions between of runx2 and ATF4.17,20,24 The upregu-
lation of runx2 and the unaltered expression of ATF4
seemingly explains the mild increase in osteocalcin. Although
osteocalcin is commonly utilized as a marker for terminally
differentiated osteoblast, its role in bone formation remains
uncertain. Osteocalcin-deficient mice have higher bone mass
and bones of improved functional quality compared to the
wild type.25 Therefore, the exaggerated expression of
osteocalcin does not necessarily ensure normal osteoblast
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function. Further examination on the ability of osteoblast to
produce bone matrix illustrated comparable amount of
collagen-containing matrix nodules in normal and low pH
suggesting that chronic metabolic acidosis preferentially
inhibits bone matrix mineralization.
Our study is the first to show the effect of chronic
metabolic acidosis on sequential changes of gene expression
of hMSCs during the process of osteoblast differentiation.
Chronic metabolic acidosis upregulates runx2 and its related
genes whereas attenuating osterix and alkaline phosphatase
resulting in an overall reduction in bone formation. The
imbalance between runx2-associated genes and osterix may
adversely affect osteoblast differentiation. Our results confirm
those of others on the reduction of alkaline phosphatase and
impaired bone matrix mineralization.7,26,27 However, con-
flicting data exists on the expression type I collagen and
osteocalcin. In the previous study by Frick et al.,28 short-term
exposure of mouse calvarial bone cells to acidic pH resulted
in a decreased type I collagen mRNA. Recently, Brandao-
Burch et al.27 demonstrated collagen synthesis from rat
calvariae-osteoblasts to be unaffected by acidosis. Staining of
matrix-containing nodules by Masson’s trichrome showed no
differences in the quantity or organization of collagen fibrils
at physiologic or acidic pH. Similar to the data from
Brandao-Burch et al.,27 our study revealed comparable
amount of collagen-containing matrix nodules in normal
and low pH. Recently, the increase in osteocalcin protein
within the bone matrix of dRTA patients was demonstrated
after successful treatment with alkaline.6 Furthermore, others
have observed the improvement in serum osteocalcin after
correction of metabolic acidosis.29,30 Notably, data on the
positive impact of acidosis correction on osteocalcin was
entirely from in vivo studies. Metabolic acidosis has been
known to affect cell abundance both in vivo and in vitro. For
example, the decreased osteoblast number was observed in
the bone sections of dRTA and partly restored by alkaline
therapy.4,5 Osteocalcin is produced almost exclusively by
osteoblasts; therefore, any variation in the cell abundance will
likely alter the amount of the secreted protein.31 In this study,
metabolic acidosis has been shown to attenuate cellular
proliferation. Thus, the increase in osteocalcin after acidosis
correction in vivo may be due to the positive influence of
metabolic acidosis on cell abundance. Nevertheless, caution
must be applied when interpreting in vitro data that
eliminates the influences of other in vivo factors such as
alterations in mineral balance or inhibition of skeletal
anabolic factors that may play substantial roles in bone
remodeling during metabolic acidosis.
Owing to the in vitro nature of our study, DEX was
required to drive the differentiation of MSCs into osteoblasts
and the action of DEX could be altered by metabolic acidosis.
MSCs are heterogeneous consisting not only multipotent
stem cells but also more restricted osteoprogenitors.32 The
negative control experiments carried out in the absence of
DEX representing the effect of metabolic acidosis on these
committed osteoprogenitors revealed similar findings to the
experiments performed with DEX indicating that any effect
metabolic acidosis had on the action of DEX was negligible.
Variability in the data on gene expression from both donors
are observed in our study. MSCs are known for their
heterogeneity. Colony growth from the newly adherent cells
varies in size, morphology, and potential for differentiation.
This property has been observed in our lab as well as
others.13,32 Therefore, when using the cells from different lots
or donors, variability of the results can be expected. Despite
this limitation, the effect of metabolic acidosis on the gene
expression is relatively preserved.
In summary, the inhibitory effect of chronic metabolic
acidosis on bone formation is largely due to the impairment
of bone matrix mineralization. Chronic metabolic acidosis
has diverse impact on osteoblastic genes. The differentiation
of osteoblast was altered and its function was attenuated.
Coordinated and appropriate expressions of osteoblastic
genes in a timely manner are necessary to ensure normal
osteoblast function. Our data suggests that the imbalance
between runx2 and osterix pathway may have unfavorable
impact on osteoblast differentiation and bone formation
during metabolic acidosis.
MATERIALS AND METHODS
Reagents
Tissue culture media and reagents were obtained from GibcoBRL,
NY, USA. Other chemical reagents (unless otherwise specified) were
supplied by Sigma, MO, USA.
Isolation and culture of bone marrow derived MSCs
Bone marrow samples were obtained from two healthy bone marrow
donors (donor 1, a 20-year-old male and donor 2, a 32-year-old
female) after informed consents. Bone marrow mononuclear cells
were separated by density gradient centrifugation with Percoll
solution. A total of 2 106 cells/ml were expanded in Dulbecco’s
modified Eagle’s medium with 10% fetal bovine serum and 1%
penicillin–streptomycin at 371C in 5% CO2 incubator. The detached
cells were discarded every 4 day. Upon 90% confluency, MSCs were
trypsinized and passaged for the next expansion. This study has
been approved by ethical committee on Research Involving Human
Subjects at Ramathibodi hospital, Mahidol University. All experi-
ments were performed using MSCs from donor 1 unless specified
otherwise.
Flow cytometry analysis
Freshly isolated bone marrow mononuclear cells and those derived
at the end of the fourth passage were incubated with the following
monoclonal antibodies, CD-14PE, CD-34FITC, CD45-FITC, HLA-
DR PE, and CD-105FITC (Becton-Dickinson Pharmingen, Heidel-
berg, Germany). Flow cytometry analysis was performed using
Cellquest software program.
Osteogenic and adipogenic differentiation
Studies were performed using the cells between passages 4–8. MSCs
have been shown previously to remain undifferentiated through
multiple passages and their osteogenic potential is preserved up
until passage 10–15.33 A normal karyotype and telomerase activity
were found to be maintained even at passage 12.13 MSCs were plated
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in six-well tissue culture plates at an initial density of 5 103 cells/
cm2. At 50–60% confluency, DEX 100 nM, b-glycerophosphate
10 mM, and ascorbate phosphate 0.1 mM were added to induce
osteogenic differentiation. This medium is referred to as OM.
Increasing amount of HCl was added to Dulbecco’s modified Eagle’s
mediumþ 10% fetal bovine serum and 1% penicillin–streptomycin
to lower the medium pH as described previously.10 The pH was
monitored by blood gas analyzer. Adipogenic differentiation
medium contained DEX 1mM, 3-isobutyl-1 methylxanthine
100mg/ml, and insulin 2 mg/ml. Medium was changed twice weekly.
Cell proliferation and cytotoxicity assays
Cell proliferation was evaluated by 3-(4,5-dimethyl-thiazolyl-2)-2,5-
diphenyltetrazolium bromide assay. One milliliter of 0.5 mg/ml 3-
(4,5-dimethyl-thiazolyl-2)-2,5-diphenyltetrazolium bromide solu-
tion was added to each well of 12-well plates. After 3 h of incubation
intracellular purple formazan was solubilized with 1 ml of 0.04 M
HCl in absolute isopropanol. Absorbance was recorded at 570 nm
with background subtraction at 650 nm. Cytotoxicity was evaluated
by lactate dehydrogenase-Cytotoxicity Assay Kit (Biovision, CO,
USA) as described by the manufacturer. Adherent cells were
incubated in the assay medium containing 1% fetal bovine serum
with and without increasing concentration of HCl for upto 24 h.
Cells incubated in the assay medium with 1% Triton X-100 served as
positive control. Absorbance of lactate dehydrogenase activity
released from damaged cells was recorded at 490 nm with reference
wavelength of 650 nm. Cytotoxicity was calculated as percentage of
lactate dehydrogenase release from HCl cultures compared to
positive control. Assays were performed in duplicate.
Studies of osteoblastic gene expression by quantitative real-
time reverse transcription-PCR
Total RNA from the cells was isolated using Trizol (Life
Technologies, NY, USA). Complementary DNAs were reverse
transcribed using Reverse Transcription System (Promega, WI,
USA). Quantitative real-time reverse transcription-PCR was per-
formed using ABI Prism 7000 Sequence Detection System (Applied
Biosystems, CA, USA) in 25 ml reaction of Taqmans PCR
mastermix. Multiplexed PCR reaction was performed with both
target and reference genes (18S ribosomal RNA (rRNA)) in the same
reaction. Each sample was analyzed in triplicate. The probe for 18S
rRNA was fluorescently labeled with VICTM and TAMRA, whereas
the probes for gene of interest were labeled with 6-carboxyfluor-
escein and TAMRA. The nucleotide sequences of primer and probe
are shown in Table 2. Relative expression levels of the gene of
interest, normalized by the amount of 18S rRNA, were calculated.
The average values of DCts from each sample were used for statistical
analysis.
Western blot analysis
Adherent cells were lysed in cold cell lysis buffer (50mM Tris, 150 mM
NaCl, 10 mM ethylenediaminetetraacetic acid, 1%Triton-X) with
1:10 Protease Inhibitor Cocktail (AEBSF, aprotinin, leupeptin,
bestatin, pepstatin A, and E-64) followed by vigorous pipetting
and centrifugation. Protein (10–20 mg) was heated for 5 min at 951C
in sample buffer (Leammli), loaded onto a 10% polyacrylamide-
sodium dodecyl sulfate gel and transfer onto nitrocellulose
membrane. After blocking with 5% non-fat dry milk, the membrane
was probed with following primary rabbit polyclonal antibodies,
runx-2, ATF-4, actin (Santa Cruz, Santa Cruz, CA, USA), and
osterix (Abcam, UK). Membranes were washed and reprobed with
goat anti-rabbit horseradish peroxidase conjugated secondary anti-
body and visualized by enhanced chemiluminescence detection
(Pierce, Rockford, IL, USA).
Sirius red staining and quantification of collagen concentration
The experiments were performed in 25-mm2 tissue culture dishes.
The staining and quantification protocol has been described
previously.19 Cell layers were fixed for 1 h in Bouin’s fixative
followed by addition of Sirius red F3BA solution (0.1% in saturated
picric acid). After 1-h staining, cell layers were washed in running
tap water and again in 0.01 N HCl to remove the non-bound dye. For
quantification of collagen content, the dye was dissolved in 0.1 N
NaOH. The absorbance was determined at 550 nm. The amount of
collagen was normalized by the protein concentration using
Bradford Reagent. Assays were performed in duplicate.
Alkaline phosphatase enzyme activity assay
The experiments were performed in 12-well tissue culture plates.
About 0.3 ml of 2 mg/ml p-nitrophenyl phosphate solution in 0.75 M
2-amino-2-methyl-1-propanol/2 mM magnesium chloride, pH 10.3,
was added to each well. Cells were incubated at 371C for 30 min and
the reaction was stopped by 0.3 ml of 50 mM NaOH. Absorbance was
determined at 405 nm and normalized by protein concentration.
Standard curve was constructed using p-nitrophenol standard
solution. Assays were performed in duplicate.
Table 2 | Primer and probe sequences
Gene Forward and reverse primers (50–30) Probe (50–30)
18S rRNA CGGCTACCACATCCAAGGAA
GCTGGAATTACCGCGGCT
TGCTGGCACCAGACTTGCCCTC
Runx2 GCCTTCAAGGTGGTAGCCC
CGTTACCCGCCATGACAGTA
CCACAGTCCCATCTGGTACCTCTCCG
Osterix CCCCACCTCTTGCAACCA
CCTTCTAGCTGCCCACTATTTCC
CCAGCATGTCTTGCCCCAAGATGTCTA
ATF4 TGGCTGGCTGTGGATGG
TCCCGGAGAAGGCATCCT
TGGTCAGTCCCTCCAACAACAGCAAG
Type I collagen CAGCCGCTTCACCTACAGC
TTTTGTATTCAATCACTGTCTTGCC
CCGGTGTGACTCGTGCAGCCATC
Alk Phos GACCCTTGACCCCCACAAT
GCTCGTACTGCATGTCCCCT
TGGACTACCTACCTATTGGGTCTCTTCGAGCCA
Osteocalcin GAAGCCCAGCGGTGCA
CACTACCTCGCTGCCCTCC
TGGACACAAAGGCTGCACCTTTGCT
rRNA, ribosomal RNA.
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Measurement of calcium content
The deposition of calcium in mineralization nodules was deter-
mined based on calcium-o-cresolphthalein complexone method.
Decalcification was performed by adding 200–500 ml of 0.6 N HCl
into each well of a 12-well tissue culture plate and left overnight at
41C. 50 ml of samples were transferred to the test tubes containing
1 ml of colored solution (0.1% o-cresolphthalein complexone/1%
8-hydroxyquinoline) and 1 ml of 2-amino-2-methyl-1-propanol
pH 10.7. Absorbance was determined at 575 nm and normalized
by protein concentration. Serially diluted stock CaCO3 was used as
standards. Assays were performed in duplicate.
Von Kossa staining
The experiments were performed in 25-mm2 tissue culture dishes.
Cell layers were fixed with 10% formalin, washed thoroughly with
distilled water and incubated with 2% silver nitrate for 15 min.
Statistical analysis
Results are presented as mean7s.e.m. Student t-test was used to
compare group means of two samples. The difference was
considered significant at P-value below 0.05.
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